IMMUNSUPPRESSIVE FORMULIERUNG

Patent europeic · EP3129006 · En vigur

Inscripziun en il register

Numer da publicaziun
EP3129006
Numer da la dumonda
EP15735733
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
En vigur
Scrittira da patent
Concedì
Annunzià
08-04-2015
Publitgà
15-02-2017
Concedì
27-01-2021
La protecziun finescha il pli tard
07-04-2035
Proxima taxa annuala scadenta
30-04-2027
Classas IPC
A61K 9/16 (2006.01)
A61K 9/20 (2006.01)
A61K 9/28 (2006.01)
A61K 31/397 (2006.01)
Prioritad
US 201461977806 P 10.04.2014
Dumonda PCT
PCT/IB2015/052552 08.04.2015
Publicaziun PCT
WO2015/155711 15.10.2015
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 01-05-2026

    Midada

    Published in Swissreg on 01.05.2026

  2. 01-05-2025

    Midada

    Published in Swissreg on 01.05.2025

  3. 01-05-2024

    Midada

    Published in Swissreg on 01.05.2024

  4. 01-05-2023

    Midada

    Published in Swissreg on 01.05.2023

  5. 08-12-2021

    Midada

    Published in Swissreg on 08.12.2021

  6. 27-01-2021

    Concedì

    Published in Swissreg on 27.01.2021

Partidas

Possessur

Novartis AG

Lichtstrasse 35, 4056 Basel

Inventur

REYNAUD, Emeric

4002 Basel

BOUILLOT, Philippe Michel Rene

4002 Basel

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.